🇺🇸

US SEC Filing Intelligence

· daily

US Merger & Acquisition SEC Filings — October 08, 2026

This M&A and takeover stream covers nine 8-K filings dated October 7-8, 2026, dominated by SPAC activity: four SPAC-related filings concern IPO closings, extensions, charter amendments or adjournments, while the substantive deal flow is concentrated in three pending or approved business combinations (Calisa/Goodvision AI, Charlton Aria/KQC Quantum, and Digital Asset Acquisition/Titan Strategics uranium). The most material developments are Calisa's shareholder approval of its Goodvision AI business combination with strong For votes (5,903,693 For vs 174,200 Against), the Charlton Aria/KQC Quantum investor webcast on October 8 at 10:30 a.m. ET following a October 6 agreement, and the Digital Asset Acquisition/Titan Strategics deal, which carries a $318 million pro-forma enterprise value but unverified SK-1300 drilling data. Newly launched SPACs (Leader's Advantage with $151.1 million in trust; Southport Acquisition Corp. II with $212.1 million in trust) show continued SPAC IPO issuance, though Leader's Advantage carries a going-concern opinion with no target identified. The stream's financial data is limited: the filings do not provide period-over-period financial comparisons, so trend analysis is confined to deal terms, vote tallies, trust sizing and deadlines. Overall, the stream reflects a SPAC ecosystem in which near-term catalysts are deal closings and extension deadlines rather than fundamental earnings momentum.

9 high priority 9 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 08, 2026

Overnight SEC filings were dominated by insider activity, with a clear cluster of director equity awards at Wave Life Sciences (WLES) and routine tax-related transactions at Coherent Corp. and Streamex Corp. No major 10-K/10-Q earnings releases, M&A, or guidance updates were filed overnight. The most notable signal is the coordinated Wave Life Sciences director compensation package (10 directors each receiving restricted stock and options), suggesting management alignment ahead of upcoming catalysts. Streamex Corp. shows insider selling at low prices, a mildly bearish signal. Overall, the tape is quiet with no material fundamental news.

34 high priority 16 medium 50 total filings
· daily

Biotech Small-Cap Approvals — October 07, 2026

This digest covers 2 FDA approvals from October 2-5, 2026, comprising 0 NMEs, 1 biosimilar, and 1 'Other' (fallback) approval, with no dominant therapeutic area theme. The highest-conviction signal is Aurobindo Pharma Ltd's biosimilar approval for Perampanel (ANDA220492), which is bullish for the entrant as it opens a new revenue stream in the biosimilar market, though bearish for the undisclosed originator. The key risk is the lack of reference product identity for Perampanel, making revenue erosion and market dynamics unquantifiable. Piramal Critical Care's Desflurane approval is a neutral, low-materiality event with no disclosed commercial data.

2 total filings
· daily

Orphan Drug Approvals — October 07, 2026

This period recorded a single, low-conviction Orphan Drug approval, with zero NMEs, zero biosimilars, and zero label expansions, resulting in a muted investment signal. The sole event was a 'FALLBACK' approval for PIRTOBRUTINIB (JAYPIRCA) by LOXO ONCOL, classified as a label expansion but lacking disclosed commercial data on peak sales, exclusivity, or pricing power. The absence of NME or biosimilar activity provides no clear therapeutic area clustering or sponsor pipeline momentum. The highest-conviction signal is a weak bullish (5/10) for PIRTOBRUTINIB, but the lack of detail on market position or near-term catalysts limits actionable insight. Key risk is the opaque nature of this approval—without indication size or competitive context, investors cannot assess revenue impact or IRA exposure for LOXO ONCOL's portfolio.

1 total filings
· daily

New Drug Approvals (Original) — October 07, 2026

During the period of October 7, 2026, the FDA approved two products: one biosimilar (PERAMPANEL by Aurobindo Pharma) and one other/fallback approval (DESFLURANE by Piramal Critical), with no NMEs or label expansions. The approvals are limited to the biosimilar and generic space, with no dominant therapeutic area theme emerging. The highest-conviction signal is the biosimilar approval of PERAMPANEL for Aurobindo, which is bullish for the entrant as it opens a new revenue stream with typical biosimilar discounts, but bearish for the undisclosed originator due to expected revenue erosion. Key risks include the lack of reference product details, which limits assessment of market impact, and the neutral signal for DESFLURANE, which offers limited commercial upside. Investors should watch for launch details and potential interchangeability rulings for PERAMPANEL.

2 total filings
· daily

Federal Construction & Infrastructure Contracts — October 07, 2026

During the period, two civilian construction contracts totaling $273 million were awarded by the Department of Homeland Security (DHS) to Tutor Perini Corporation and Southwest Valley Constructors Co, both for U.S. Customs and Border Protection (CBP) facility construction. The contracts are firm-fixed-price, full-and-open competitive awards, indicating strong competitive positioning for both contractors, but also carrying medium execution risk due to fixed-price structures. The dominant theme is continued DHS investment in border infrastructure, with no defense-related awards. The highest-conviction signal is the sustained federal construction pipeline for large contractors, though the one-time nature of these projects limits recurring revenue visibility. Key watch items include potential cost overruns on fixed-price contracts and the broader impact of continuing resolution uncertainty on future DHS infrastructure spending.

2 total filings
· daily

DHS Homeland Security Contracts — October 07, 2026

Over a single day, the Department of Homeland Security obligated $455.1 million across three contracts, all civilian and all awarded under full-and-open competition with no set-asides, signaling robust, merit-based procurement activity. The dominant theme is DHS/CBP border infrastructure investment, with two large construction awards to Tutor Perini ($144M) and Southwest Valley Constructors ($129M) for new CBP facilities, while MVM, Inc. received the largest single award ($182.1M) for ICE transportation services for unaccompanied minors. The highest-conviction signal is the stable, high-value demand for immigration-related security services, but the time-and-materials pricing structure on MVM’s contract introduces execution risk. Key watch items include potential policy changes affecting ICE’s mission and cost-overrun risks on the fixed-price construction contracts.

3 total filings
· daily

New Federal Contractors — October 07, 2026

This digest covers six new federal contractor awards totaling $907.3 million, all from civilian agencies with zero defense-related contracts, signaling a pronounced shift in procurement activity toward homeland security and justice infrastructure. The Department of Homeland Security dominates the period with three awards—to MVM, Inc. ($182.1M for ICE transportation), Tutor Perini ($144M for a CBP facility), and Southwest Valley Constructors ($129M for another CBP facility)—aggregating $455.1 million, or 50% of total obligation. The highest-conviction signal is V2X Systems LLC’s $166.3 million sole-source award from DOJ, which carries a $1.7 billion potential ceiling if all options are exercised, indicating a deep, non-competitive relationship. Key risks include the fixed-price construction contracts (Tutor Perini, Southwest Valley) exposing margin compression from material cost inflation, and MVM’s politically sensitive immigration mission facing policy-driven disruption. Investors should monitor first outlays on V2X and any re-compete challenges to the sole-source award.

6 total filings
· daily

Significant Contract Modifications ($10M+) — October 07, 2026

This digest covers six significant contract modifications totaling $907.3 million, all from civilian agencies (0% defense-related), with an average signal strength of 4.8/10. The Department of Homeland Security dominates, accounting for $455.1 million (50.2%) across three awards to MVM, Inc., Tutor Perini, and Southwest Valley Constructors for immigration services and border infrastructure. The highest-conviction signal is V2X Systems LLC's $166.3 million sole-source award from DOJ, implying a durable competitive moat, though the time-and-materials pricing and lack of outlays to date introduce execution uncertainty. Key risks include political sensitivity around ICE's immigration mission and fixed-price construction exposure for Tutor Perini and Southwest Valley Constructors. No bullish or bearish signals were identified; all six contracts are rated neutral, reflecting mature, non-catalytic procurement activity with limited near-term investment catalysts.

6 total filings
· daily

Contract Deobligations Alert — October 07, 2026

This digest of six contracts totaling $907.3 million reveals a **purely civilian government spending story** with zero defense exposure, dominated by the Department of Homeland Security (DHS). The highest-conviction signal is a **$1.7 billion potential sole-source award** to **V2X Systems LLC** for DOJ legal support, though current obligations are only $166.3 million with no outlays yet, creating a high-risk/high-reward catalyst. The dominant sector theme is **DHS border and immigration infrastructure**, with three awards totaling **$455.1 million** to MVM, Inc., Tutor Perini, and Southwest Valley Constructors for transportation and facility construction. A key risk is the **time-and-materials pricing** on the two largest contracts (MVM and V2X), which introduces cost variability and execution risk. No bullish or bearish signals were identified across the six neutral-rated contracts, but the concentration in civilian agencies makes this cohort vulnerable to a government shutdown or Continuing Resolution (CR) that disrupts DHS and DOJ funding.

6 total filings
· daily

Contract Option Exercises — October 07, 2026

This digest covers $907.3 million in contract option exercises across six awards, all from civilian agencies (0% defense-related), with an average signal strength of 4.8/10. The dominant theme is Department of Homeland Security (DHS) spending, particularly through ICE and CBP, which accounts for $455.1 million (50.2%) of the total across three awards to MVM, Inc., Tutor Perini, and Southwest Valley Constructors. The highest-conviction signal is V2X Systems LLC’s $166.3 million sole-source award from DOJ, which carries a $1.7 billion potential ceiling if all options are exercised, signaling a strong competitive moat. Key risks include the time-and-materials pricing on the two largest awards (MVM and V2X) exposing contractors to cost variability, and the political sensitivity of ICE’s immigration enforcement mission. No bullish or bearish signals were identified; all six contracts are rated neutral, reflecting balanced risk-reward profiles with no clear catalysts for outperformance or underperformance.

6 total filings
· daily

Mega Contracts Monitor ($100M+) — October 07, 2026

The six contracts totaling $907.3 million are entirely civilian, with zero defense-related awards, signaling a notable concentration in Department of Homeland Security (DHS) spending—particularly Immigration and Customs Enforcement (ICE) and Customs and Border Protection (CBP). The highest-conviction signal is the $182.1 million MVM, Inc. delivery order for ICE transportation services, which reflects stable demand for immigration enforcement but carries political sensitivity and time-and-materials execution risk. The two large CBP facility construction awards to Tutor Perini ($144M) and Southwest Valley Constructors ($129M) reinforce a theme of physical infrastructure investment, though both are fixed-price contracts vulnerable to cost overruns. A key risk is the $166.3 million V2X Systems LLC sole-source DOJ award, which has no outlays yet and could face protest or budget delays. Overall, the digest reveals no bullish or bearish signals, only neutral ones, with the most actionable insight being the civilian infrastructure and services theme driven by DHS border and immigration priorities.

6 total filings
· daily

High-Value Federal Grants ($5M+) — October 07, 2026

The six contracts analyzed, totaling $907.3 million, are entirely civilian in nature, with zero defense-related awards, signaling a notable divergence from typical government spending patterns. The Department of Homeland Security (DHS) dominates the digest, accounting for $455.1 million (50%) across three awards to MVM, Inc., Tutor Perini, and Southwest Valley Constructors for immigration enforcement and border infrastructure. The highest-conviction signal is V2X Systems LLC’s $166.3 million sole-source award from DOJ, which carries a $1.7 billion potential ceiling but has zero outlays to date, creating a binary catalyst. A key risk is the heavy concentration in DHS immigration-related services, which are politically sensitive and vulnerable to policy shifts, while the digest lacks any high-growth technology or defense modernization exposure.

6 total filings
· daily

General Federal Contracts — October 07, 2026

This digest covers $907.3 million in federal contract obligations during a period with zero defense-related awards, highlighting a strong civilian-agency skew toward the Department of Homeland Security (DHS), particularly ICE and CBP. The largest award—$182.1 million to MVM, Inc. for ICE transportation services—underscores stable demand for immigration enforcement support, but potential political sensitivity and a fixed one-year term introduce signal uncertainty. The most material contract is the $166.3 million sole-source award to V2X Systems LLC by DOJ for international asset recovery, carrying a potential ceiling of $1.7B, though no funds have been outlaid yet, raising execution timing risk. Two CBP facility construction contracts to Tutor Perini Corporation ($144M) and Southwest Valley Constructors Co ($129M) reinforce DHS infrastructure spending but carry fixed-price execution risk. Overall, the digest reveals a civilian-focused procurement pipeline concentrated in DHS, with moderate execution risk across time-and-materials and fixed-price structures, and no bullish or bearish signal above neutral. Key watch items include V2X’s first outlays, MVM’s political risk from immigration policy shifts, and fixed-price margin pressures on Tutor Perini and Southwest Valley.

6 total filings
· daily

S&P 500 Technology Sector SEC Filings — October 07, 2026

The two filings from Analog Devices and Synopsys both reveal insider selling activity, creating a cautious tone within the S&P 500 Technology sector. While the sales are relatively modest in size and executed under pre-arranged 10b5-1 plans, they occur at a time when no other bullish signals (such as insider buying, raised guidance, or strong period-over-period growth) are present in the data. The lack of forward-looking statements, capital allocation changes, or positive sentiment from either company amplifies the bearish undertone. For investors, this suggests a period of management profit-taking or portfolio rebalancing rather than outright distress, but it warrants monitoring for any acceleration in selling. The absence of any positive catalysts or growth metrics in the enriched data leaves a neutral-to-negative near-term outlook for these two names.

2 high priority 2 total filings
· daily

Nasdaq 100 Stocks SEC Filings — October 07, 2026

The four NASDAQ-100 filings for October 7, 2026, reveal a bifurcated market picture: robust operational performance from Costco, contrasted with a wave of insider selling at Analog Devices, Meta Platforms, and Starbucks. Costco's 10-K shows strong top-line growth (+10% YoY), improving operating cash flow, and stable margins, reinforcing its defensive growth profile. However, the three Form 4 filings signal a notable cluster of insider profit-taking by senior executives at Analog Devices, Meta, and Starbucks, all executed under 10b5-1 plans, which may indicate a pre-planned, non-alarming diversification but still warrants monitoring for sentiment shifts. The absence of forward-looking guidance, capital allocation changes, or M&A activity in the insider filings limits the depth of trend analysis, but the concentration of sales across different sectors (semiconductors, social media, consumer discretionary) suggests a broader pattern of insider liquidity events rather than company-specific distress. The key takeaway is that while Costco's fundamentals remain strong, the insider selling cluster creates a subtle undercurrent of caution for the broader index.

4 high priority 4 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — October 07, 2026

The October 7, 2026 filing batch reveals a market dominated by passive institutional repositioning, with Fidelity (FMR LLC) alone accounting for 24 of the 50 filings, adjusting stakes across a diverse portfolio including significant positions in Repligen (13.0%), Skyworks (12.6%), and ExlService (12.0%). Notable activist and strategic moves include Mid Penn Bancorp's regulatory approval to potentially increase ownership to 24.99%, Bitfury's forward contract settlements reducing its Cipher Mining stake, and Stone House Capital's exit from Designer Brands options. Insider activity is limited but telling: Madrone Partners sold 750,000 StoneCo shares at an average $11.90, while Pompliano's passive stake in Silvia rose to 18.45% purely from buybacks. The overall sentiment is neutral, with no major guidance changes or aggressive capital allocation shifts, but the data reveals a clear pattern of large investors trimming or maintaining positions rather than accumulating, suggesting a cautious stance. Key sector themes include continued institutional conviction in biotech and semiconductors, passive ownership creep in small caps, and a notable absence of activist campaigns, indicating a wait-and-see approach ahead of earnings season.

7 high priority 43 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 07, 2026

This digest covers 8 filings from S&P 500 Financials constituents, dominated by insider selling activity and routine corporate updates. The most significant signal is a massive $22.1M stock sale by Robinhood's CEO Vladimir Tenev, executed under a 10b5-1 plan but representing a near-total liquidation of his direct holdings (reducing to just 22,192 shares). This is compounded by the CLO selling $1.1M and the parent company selling fund shares, creating a concentrated bearish insider pattern at Robinhood. Capital One's General Counsel also sold $687K in stock. On the neutral side, three Morgan Stanley crypto trusts (Ethereum, Bitcoin, Solana) disclosed a shared routine personnel change—appointing Craig Abruzzo as Co-COO of the sponsor—with no financial impact. Aflac saw a 10% owner, Japan Post Holdings, sell a small $1.46M position. The overarching theme is a lack of bullish insider activity and an absence of forward-looking guidance or capital allocation catalysts in this batch, creating a cautious tone for the financials sector.

5 high priority 3 medium 8 total filings
· daily

S&P 500 Energy Sector SEC Filings — October 07, 2026

APA Corp's preliminary Q3 2026 estimates reveal a mixed operational picture with strong realized oil prices ($87.50/bbl US, $98.50/bbl international) offset by $25 million in dry hole costs and low NGL volumes pressuring international pricing. The company's aggressive $449 million share buyback (10.5M shares at $42.78) signals management's confidence in intrinsic value, though the preliminary nature of the filing and $115 million in G&A expenses (48.7% from stock-based compensation) warrant caution. A $190 million net gain on oil and gas purchases/sales, including $8 million from commodity derivatives, provides a non-operational earnings boost. The 36 MBoe/d Egypt tax barrel contribution underscores APA's international exposure, which carries geopolitical risk. Overall, the filing suggests a company balancing strong cash generation with disciplined capital returns, but the lack of period-over-period comparisons limits trend analysis.

1 medium 1 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 07, 2026

The 13 filings from the S&P 500 Consumer Staples sector reveal a mixed picture of operational strength, insider confidence, and structural shifts. Costco's 10-K highlights robust 10% revenue growth and improving SG&A efficiency, reinforcing its position as a sector leader. In contrast, the Clorox filings are dominated by procedural proxy materials and routine insider equity awards, indicating stable governance but no new strategic catalysts. Kraft Heinz's segment reorganization signals a push for operational efficiency in emerging markets, while Hershey's 10% owner selling $1.37M under a 10b5-1 plan introduces a modest overhang. The lack of forward-looking guidance across most filings limits near-term catalyst visibility, but Costco's strong cash flow and capital allocation trends stand out as a key positive. Overall, the sector shows resilience with pockets of outperformance, though insider selling at Hershey and the absence of growth catalysts at Clorox warrant caution.

10 high priority 3 medium 13 total filings